Latest Advances

  • Condition: Atypical Hemolytic Uremic Syndrome (aHUS)
  • Journal: The American journal of case reports
  • Treatment Used: Hemodialysis, Corticosteroids, Plasma Exchange, and Eculizumab
  • Number of Patients: 1
  • Published —
This case report describes a 58-year-old man diagnosed with atypical hemolytic uremic syndrome (aHUS) treated with hemodialysis, corticosteroids, plasma exchange, and eculizumab.
  • Condition: Pediatric Patients with Hemophilia
  • Journal: Acta ortopedica mexicana
  • Treatment Used: Virtual Reality Rehabilitation
  • Number of Patients: 11
  • Published —
The study researched the outcomes of virtual reality rehabilitation for treating pediatric patients with hemophilia.
  • Condition: Severe or Moderately Severe Hemophilia A
  • Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Treatment Used: Antihemophilic Factor
  • Number of Patients: 72
  • Published —
This study tested the safety and efficacy of using antihemophilic factor to treat patients with severe or moderately severe hemophilia A.
  • Condition: Hemophilia
  • Journal: Frontiers in immunology
  • Treatment Used: Plasma-Derived vs. Recombinant Factor VIII Products
  • Number of Patients: 0
  • Published —
This article discusses immune responses to plasma-derived versus recombinant factor VIII products in patients with hemophilia.
  • Condition: Spinal Epidural Hematoma with Hemophilia A
  • Journal: The Journal of international medical research
  • Treatment Used: Conservative Therapy with High-Titer VIII Inhibitors
  • Number of Patients: 1
  • Published —
This case report describes a patient with hemophilia A that experienced a spinal epidural hematoma.
  • Condition: Acquired Hemophilia A (AHA)
  • Journal: Medicine
  • Treatment Used: Rituximab and rFVIIa
  • Number of Patients: 1
  • Published —
This article reviewed the case of a patient with acquired hemophilia A (bleeding disorder that interferes with the body's blood clotting process; AHA) treated with rituximab and rFVIIA.
  • Condition: Congenital Hemophilia in Malaysia
  • Journal: The Medical journal of Malaysia
  • Treatment Used: Emicizumab Prophylaxis, PEGylated Recombinant Anti-Hemophilic Factor, Radiosynovectomy
  • Number of Patients: 96
  • Published —
This study determined the outcome of patients with congenital hemophilia in Malaysia.
  • Condition: Intrahepatic Combined Hepatocellular Carcinoma Recurrence with Hemophilia, HIV, and Hepatitis C Virus
  • Journal: Gan to kagaku ryoho. Cancer & chemotherapy
  • Treatment Used: Hepatectomy
  • Number of Patients: 1
  • Published —
This case report describes a patient with intrahepatic combined hepatocellular carcinoma recurrence with hemophilia, HIV, and hepatitis C virus.
  • Condition: Ascending Colon Cancer with Hemophilia A
  • Journal: Gan to kagaku ryoho. Cancer & chemotherapy
  • Treatment Used: Laparoscopic Right Hemicolectomy and a Blood Coagulant Factor-A
  • Number of Patients: 1
  • Published —
This case report describes a patient with ascending colon cancer and hemophilia A.
  • Condition: Hemophilic Arthropathy and Lesion of the Musculoskeletal Apparatus
  • Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • Treatment Used: Surgery with Clotting Factor Replacement Therapy
  • Number of Patients: 261
  • Published —
The study researched the outcomes of surgery with clotting factor replacement therapy for treating hemophilic arthropathy and lesion of the musculoskeletal apparatus.
  • Condition: Acquired Hemophilia A (AHA) in Woman with Systemic Lupus Erythematosus (SLE)
  • Journal: Medicine
  • Treatment Used: Transfusion of Recombinant Human FVIII (ADVATE) Combined with Intravenous Methylprednisolone, Cyclophosphamide, Plasmapheresis, and Fresh Frozen Plasma
  • Number of Patients: 1
  • Published —
This case report describes a 51-year-old female patient with systemic lupus erythematosus (SLE) diagnosed with acquired hemophilia A (AHA) treated with transfusion of recombinant human FVIII (ADVATE) in combination with intravenous methylprednisolone, cyclophosphamide, plasmapheresis, and fresh frozen plasma.
  • Condition: Severe hemophilia A
  • Journal: Annals of hematology
  • Treatment Used: Two Extended Half-Life PEGylated Recombinant FVIII Products
  • Number of Patients: 18
  • Published —
This study compared two extended half-life PEGylated recombinant FVIII products in patients with severe hemophilia A.
Showing 1-12 of 116